OHRP COVID-19 Guidance
The Office for Human Research Protections (OHRP) has provided guidance on COVID-19. Read More >>
Updated FDA Guidance for COVID19
“FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency,” updated on September 21, 2020.
Notification to Clients: COVID-19 Policy Exception Statement
Salus IRB issues policy exception statement for reviewing study modifications due to COVID-19.